Mycophenolate Mofetil w/ Prednisone for Immune Related Hepatitis From Checkpoint Inhibitor Therapy

Clinical trial NCT07663422 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07663422
Sponsor: Fox Chase Cancer Center
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Immune-mediated Hepatitis Immune-related Adverse Event

Start date: 2026-06-30
Primary completion: 2028-03-31
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.